S&P 500   3,188.11 (-1.17%)
DOW   27,640.00 (-1.15%)
QQQ   218.93 (-1.11%)
AAPL   294.67 (-1.18%)
FB   199.75 (-0.48%)
MSFT   171.07 (+0.11%)
GOOGL   1,415.46 (-0.31%)
AMZN   1,988.71 (-1.02%)
CGC   19.74 (-2.76%)
NVDA   260.70 (-4.60%)
BABA   206.33 (+0.08%)
MU   52.93 (-3.78%)
GE   11.51 (-2.95%)
TSLA   796.74 (-4.44%)
AMD   48.12 (-2.04%)
T   38.07 (+0.05%)
F   7.47 (-1.32%)
NFLX   360.43 (-2.24%)
BAC   31.94 (-2.41%)
DIS   130.44 (-1.93%)
GILD   69.80 (-4.25%)
S&P 500   3,188.11 (-1.17%)
DOW   27,640.00 (-1.15%)
QQQ   218.93 (-1.11%)
AAPL   294.67 (-1.18%)
FB   199.75 (-0.48%)
MSFT   171.07 (+0.11%)
GOOGL   1,415.46 (-0.31%)
AMZN   1,988.71 (-1.02%)
CGC   19.74 (-2.76%)
NVDA   260.70 (-4.60%)
BABA   206.33 (+0.08%)
MU   52.93 (-3.78%)
GE   11.51 (-2.95%)
TSLA   796.74 (-4.44%)
AMD   48.12 (-2.04%)
T   38.07 (+0.05%)
F   7.47 (-1.32%)
NFLX   360.43 (-2.24%)
BAC   31.94 (-2.41%)
DIS   130.44 (-1.93%)
GILD   69.80 (-4.25%)
S&P 500   3,188.11 (-1.17%)
DOW   27,640.00 (-1.15%)
QQQ   218.93 (-1.11%)
AAPL   294.67 (-1.18%)
FB   199.75 (-0.48%)
MSFT   171.07 (+0.11%)
GOOGL   1,415.46 (-0.31%)
AMZN   1,988.71 (-1.02%)
CGC   19.74 (-2.76%)
NVDA   260.70 (-4.60%)
BABA   206.33 (+0.08%)
MU   52.93 (-3.78%)
GE   11.51 (-2.95%)
TSLA   796.74 (-4.44%)
AMD   48.12 (-2.04%)
T   38.07 (+0.05%)
F   7.47 (-1.32%)
NFLX   360.43 (-2.24%)
BAC   31.94 (-2.41%)
DIS   130.44 (-1.93%)
GILD   69.80 (-4.25%)
S&P 500   3,188.11 (-1.17%)
DOW   27,640.00 (-1.15%)
QQQ   218.93 (-1.11%)
AAPL   294.67 (-1.18%)
FB   199.75 (-0.48%)
MSFT   171.07 (+0.11%)
GOOGL   1,415.46 (-0.31%)
AMZN   1,988.71 (-1.02%)
CGC   19.74 (-2.76%)
NVDA   260.70 (-4.60%)
BABA   206.33 (+0.08%)
MU   52.93 (-3.78%)
GE   11.51 (-2.95%)
TSLA   796.74 (-4.44%)
AMD   48.12 (-2.04%)
T   38.07 (+0.05%)
F   7.47 (-1.32%)
NFLX   360.43 (-2.24%)
BAC   31.94 (-2.41%)
DIS   130.44 (-1.93%)
GILD   69.80 (-4.25%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NOVOZYMES A/S/SSeattle GeneticsNeurocrine BiosciencesBIO-TECHNEBioNTech
SymbolOTCMKTS:NVZMYNASDAQ:SGENNASDAQ:NBIXNASDAQ:TECHNASDAQ:BNTX
Price Information
Current Price$52.75$115.27$95.69$200.84$30.52
52 Week RangeHoldBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price TargetN/A$122.12$116.92$238.33$26.13
% Upside from Price TargetN/A5.94% upside22.19% upside18.67% upside-14.40% downside
Trade Information
Market Cap$16.14 billion$19.78 billion$9.61 billion$7.90 billion$7.32 billion
Beta0.8121.531.25N/A
Average Volume14,081983,719762,183161,840249,108
Sales & Book Value
Annual Revenue$2.28 billion$916.71 million$788.10 million$714.01 million$150.67 million
Price / Sales6.8721.6611.2110.7945.83
Cashflow$1.67 per shareN/A$0.63 per share$5.82 per shareN/A
Price / Cash31.57N/A152.6934.52N/A
Book Value$6.10 per share$10.95 per share$6.92 per share$30.78 per shareN/A
Price / Book8.6510.5313.836.53
Profitability
Net Income$511 million$-158,650,000.00$37.01 million$96.07 million$-56,710,000.00
EPS$1.75($1.33)$0.39$3.80N/A
Trailing P/E Ratio32.76N/A289.9740.490.00
Forward P/E Ratio32.16N/A17.9238.85N/A
P/E Growth$2.66N/A$1.23$4.50N/A
Net Margins21.08%-17.31%4.70%26.20%N/A
Return on Equity (ROE)26.90%-13.99%8.27%12.45%N/A
Return on Assets (ROA)14.94%-11.70%3.86%7.80%N/A
Dividend
Annual Payout$0.50N/AN/A$1.28N/A
Dividend Yield0.95%N/AN/A0.64%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio28.57%N/AN/A33.68%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.23%N/A0.14%0.33%N/A
Current Ratio1.29%4.54%1.47%4.43%3.91%
Quick Ratio0.76%4.21%1.44%3.52%3.83%
Ownership Information
Institutional Ownership Percentage0.13%82.80%88.70%92.17%3.75%
Insider Ownership PercentageN/A33.80%4.30%4.20%N/A
Miscellaneous
Employees6,4271,6055852,2501,179
Shares Outstanding297.00 million172.26 million92.29 million38.35 million226.26 million
Next Earnings Date2/27/2020 (Estimated)4/23/2020 (Estimated)5/4/2020 (Estimated)5/5/2020 (Estimated)N/A
OptionableNot OptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel